Etoricoxib is contraindicated in patients with: Hypersensitivity to any component of this product.
Congestive heart failure (NYHA II-IV).
Established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease (including patients who have recently undergone coronary artery bypass graft surgery or angioplasty).
Patients with hypertension whose blood pressure is not under control.
Pregnancy.
Patients who have increased risk of cardiovascular disease (ischemic heart disease and stroke).